Terms: = Prostate cancer AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Prognosis
27 results:
1. PreImplantation Factor immunohistochemical expression correlates with prostate cancer aggressiveness.
Raspollini MR; Montagnani I; Cirri P; Baroni G; Cimadamore A; Scarpelli M; Cheng L; Lopez-Beltran A; Montironi R; Barnea ER
Int J Biol Markers; 2020 Jun; 35(2):82-90. PubMed ID: 32389051
[TBL] [Abstract] [Full Text] [Related]
2. Morbidity, perioperative outcomes and complications of robot-assisted radical prostatectomy in kidney transplant patients: A French multicentre study.
Felber M; Drouin SJ; Grande P; Vaessen C; Parra J; Barrou B; Matillon X; Crouzet S; Leclerc Q; Rigaud J; Prudhomme T; Doumerc N; Bergerat S; Lang H; Laine C; Robert G; Gobert A; Granger B; Rouprêt M
Urol Oncol; 2020 Jun; 38(6):599.e15-599.e21. PubMed ID: 31948931
[TBL] [Abstract] [Full Text] [Related]
3. Essential Updates in Grading, Morphotyping, Reporting, and Staging of prostate Carcinoma for General Surgical Pathologists.
Paner GP; Gandhi J; Choy B; Amin MB
Arch Pathol Lab Med; 2019 May; 143(5):550-564. PubMed ID: 30865487
[TBL] [Abstract] [Full Text] [Related]
4. Germline DNA Repair Gene Mutations in Young-onset prostate cancer Cases in the UK: Evidence for a More Extensive Genetic Panel.
Leongamornlert DA; Saunders EJ; Wakerell S; Whitmore I; Dadaev T; Cieza-Borrella C; Benafif S; Brook MN; Donovan JL; Hamdy FC; Neal DE; Muir K; Govindasami K; Conti DV; Kote-Jarai Z; Eeles RA
Eur Urol; 2019 Sep; 76(3):329-337. PubMed ID: 30777372
[TBL] [Abstract] [Full Text] [Related]
5. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
Epstein JI; Amin MB; Reuter VE; Humphrey PA
Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
[TBL] [Abstract] [Full Text] [Related]
6. Germline genetic variation in JAK2 as a prognostic marker in castration-resistant prostate cancer.
Zhang BY; Riska SM; Mahoney DW; Costello BA; Kohli R; Quevedo JF; Cerhan JR; Kohli M
BJU Int; 2017 Mar; 119(3):489-495. PubMed ID: 27410686
[TBL] [Abstract] [Full Text] [Related]
7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract] [Full Text] [Related]
8. Validation of copy number variants associated with prostate cancer risk and prognosis.
Blackburn A; Wilson D; Gelfond J; Yao L; Hernandez J; Thompson IM; Leach RJ; Lehman DM
Urol Oncol; 2014 Jan; 32(1):44.e15-44.e20. PubMed ID: 24054869
[TBL] [Abstract] [Full Text] [Related]
9. Common variants in IGF1 pathway genes and clinical outcomes after radical prostatectomy.
Chang CF; Pao JB; Yu CC; Huang CY; Huang SP; Yang YP; Huang CN; Chang TY; You BJ; Lee HZ; Hour TC; Bao BY
Ann Surg Oncol; 2013 Jul; 20(7):2446-52. PubMed ID: 23397154
[TBL] [Abstract] [Full Text] [Related]
10. Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on cancer Reporting.
Kench JG; Delahunt B; Griffiths DF; Humphrey PA; McGowan T; Trpkov K; Varma M; Wheeler TM; Srigley JR
Histopathology; 2013 Jan; 62(2):203-18. PubMed ID: 23240714
[TBL] [Abstract] [Full Text] [Related]
11. Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence.
Dluzniewski PJ; Wang MH; Zheng SL; De Marzo AM; Drake CG; Fedor HL; Partin AW; Han M; Fallin MD; Xu J; Isaacs WB; Platz EA
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1774-82. PubMed ID: 22859398
[TBL] [Abstract] [Full Text] [Related]
12. prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer.
Davies JD; Aghazadeh MA; Phillips S; Salem S; Chang SS; Clark PE; Cookson MS; Davis R; Herrell SD; Penson DF; Smith JA; Barocas DA
J Urol; 2011 Dec; 186(6):2221-7. PubMed ID: 22014803
[TBL] [Abstract] [Full Text] [Related]
13. Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery?
Atalay B; Yalcin S; Emes Y; Aktas I; Aybar B; Issever H; Mandel NM; Cetin O; Oncu B
Lasers Med Sci; 2011 Nov; 26(6):815-23. PubMed ID: 21809068
[TBL] [Abstract] [Full Text] [Related]
14. Genetic polymorphisms in the polycomb group gene EZH2 and the risk of lung cancer.
Yoon KA; Gil HJ; Han J; Park J; Lee JS
J Thorac Oncol; 2010 Jan; 5(1):10-6. PubMed ID: 19901851
[TBL] [Abstract] [Full Text] [Related]
15. Second opinion pathology in tertiary care of patients with urologic malignancies.
Wayment RO; Bourne A; Kay P; Tarter TH
Urol Oncol; 2011; 29(2):194-8. PubMed ID: 19523859
[TBL] [Abstract] [Full Text] [Related]
16. Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis.
FitzGerald LM; Karlins E; Karyadi DM; Kwon EM; Koopmeiners JS; Stanford JL; Ostrander EA
Prostate Cancer Prostatic Dis; 2009; 12(2):192-7. PubMed ID: 18762813
[TBL] [Abstract] [Full Text] [Related]
17. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.
Yuan TC; Veeramani S; Lin MF
Endocr Relat Cancer; 2007 Sep; 14(3):531-47. PubMed ID: 17914087
[TBL] [Abstract] [Full Text] [Related]
18. Acetylation and phosphorylation of high-mobility group A1 proteins in PC-3 human tumor cells.
Jiang X; Wang Y
Biochemistry; 2006 Jun; 45(23):7194-201. PubMed ID: 16752910
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic value of serum markers for prostate cancer.
Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
[TBL] [Abstract] [Full Text] [Related]
20. Nonsquamous cell malignant tumours of the oral cavity: an overview.
Daley T; Darling M
J Can Dent Assoc; 2003 Oct; 69(9):577-82. PubMed ID: 14653933
[TBL] [Abstract] [Full Text] [Related]
[Next]
